Halaman 2 - Glioma Dokter Terbaik - TOP-66 dokter

Seorang ahli bedah saraf terkemuka di dunia, Prof. Zvi Ram memimpin European Association of Neurosurgical Societies dan menyediakan perawatan glioma inovatif di Sourasky Medical Center.

• Ahli dalam bedah tumor otak kompleks dengan pemetaan otak dan stimulasi otak dalam
• Sangat terlatih dalam teknik bedah mikro dan panduan gambar untuk tumor otak
• Melakukan penelitian terkemuka tentang terapi berbasis gen untuk kanker otak
• Diakui dengan Goldhirsh Foundation Award untuk perawatan neurologi inovatif

Dr. Yildiz memiliki pengalaman spesialis onkologi selama lebih dari satu dekade, dengan fokus pada kasus kanker stadium lanjut di Medipol Mega University Hospital.

• Berpengalaman lebih dari 15 tahun di bidang onkologi medis
• Memegang gelar profesor di bidang onkologi – seorang ahli yang melatih dokter lain
• Telah mempublikasikan banyak karya di jurnal medis internasional tentang berbagai jenis kanker
• Anggota European Society for Medical Oncology (ESMO)
• Minat khusus pada tumor neuroendokrin dan penanganan kasus yang kompleks

Univ. Prof. Dr. Wolfgang Köstler adalah ahli terkemuka dalam pengobatan glioma, spesialis dalam terapi target dan pengobatan kanker individual di Wiener Privatklinik.

• Pengalaman lebih dari 20 tahun di bidang onkologi medis
• Fokus pada pengembangan biomarker dan biologi tumor
• Wakil Kepala Divisi Klinis Onkologi di Universitas Kedokteran Wina
• Dipublikasikan secara luas di jurnal internasional terkemuka

Profesor Keil berspesialisasi dalam teknik pencitraan tingkat lanjut untuk glioma, dengan keahlian dalam radiologi diagnostik dan intervensi di Rumah Sakit Akademik Solingen.

• Lulus dengan pujian dari Universitas Julius-Maximilian Würzburg
• Pengalaman lebih dari 16 tahun di bidang radiologi, termasuk diagnostik MRI dan CT
• Mantan dokter utama di Rumah Sakit Universitas Aachen
• Berspesialisasi dalam pencitraan cross-sectional untuk intervensi medis yang kompleks

Phd Viola Fox mengepalai Klinik Hematologi, Onkologi, dan Perawatan Paliatif di BKZ Solingen, dengan pengalaman spesialis lebih dari 15 tahun dalam perawatan glioma dan tumor lainnya.

• Berspesialisasi dalam kemoterapi, imunoterapi, dan terapi tertarget
• Berkualifikasi dalam genetika untuk meningkatkan pendekatan pengobatan yang dipersonalisasi
• Aktif dalam penelitian biologi molekuler untuk terapi kanker yang inovatif
• Menjadi anggota perkumpulan onkologi Jerman dan Amerika

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Prof. Madya Nail Paksoy adalah seorang spesialis onkologi medis yang ahli dalam perawatan glioma di Rumah Sakit Medipol Bahçelievler, dengan sertifikasi Dewan ESMO dan pengalaman penelitian yang luas.

• Menyelesaikan pelatihan fellowship di Institut Onkologi Universitas Istanbul
• Berpartisipasi dalam 8 uji klinis internasional untuk pengobatan kanker
• Menerbitkan berbagai studi tentang tumor otak dan neuro-onkologi
• Tersertifikasi Dewan ESMO dalam Onkologi Medis

Spesialisasi dalam viroterapi – salah satu bidang imunologi terbaru – dengan pengalaman 30+ tahun di Klinik Pallas.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga
• Magang di Spesialis Penyakit Dalam

Dr. Alemdar spesialis dalam Onkologi Medis dengan pelatihan ekstensif di Universitas Akdeniz – pemimpin dalam perawatan onkologi.

• Tersertifikasi dalam Onkologi Medis sejak 2018
• Pengalaman lebih dari 15 tahun di bidang onkologi
• Bekerja di Kompleks Rumah Sakit Medical Park Antalya

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Pelopor dalam menetapkan kriteria ketat untuk sindrom neurologis paraneoplastik – Dr. Graus adalah tokoh terkemuka dalam neuro-onkologi di Hospital Quiron Barcelona.

• Mantan Kepala Neurologi di Hospital Clinic, Barcelona
• Pendiri dan mantan presiden European Association of Neuro-Oncology
• Terlatih dalam neuro-onkologi di Memorial Sloan-Kettering Cancer Center
• Dianugerahi Doctor Honoris Causa oleh Lyon University

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.